Clinical Trial Update: Pharmacokinetics Study on Nevirapine Resistance in Tanzania [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study investigating nevirapine resistance in HIV infections conducted in Tanzania has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: HIV Infections | Phase 2 | Status: COMPLETED